KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $359.7 million.

  • Cme's Shares Outstanding (Weighted Average) rose 7.96% to $359.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $359.7 million, marking a year-over-year increase of 7.96%. This contributed to the annual value of $359.4 million for FY2024, which is 10.19% up from last year.
  • Latest data reveals that Cme reported Shares Outstanding (Weighted Average) of $359.7 million as of Q3 2025, which was up 7.96% from $359.7 million recorded in Q2 2025.
  • In the past 5 years, Cme's Shares Outstanding (Weighted Average) ranged from a high of $359.7 million in Q3 2025 and a low of $358.1 million during Q1 2021
  • In the last 5 years, Cme's Shares Outstanding (Weighted Average) had a median value of $358.9 million in 2023 and averaged $358.9 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first increased by 17.43% in 2021, then grew by 7.96% in 2025.
  • Cme's Shares Outstanding (Weighted Average) (Quarter) stood at $358.3 million in 2021, then rose by 0.1% to $358.7 million in 2022, then grew by 0.09% to $359.0 million in 2023, then increased by 0.1% to $359.4 million in 2024, then grew by 0.08% to $359.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $359.7 million for Q3 2025, versus $359.7 million for Q2 2025 and $359.6 million for Q1 2025.